Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00223366 · ClinicalTrials.gov registry record

In Vitro Studies on Pharmacological Regulation and Genetic Risk Factors of Peripheral Human Nociceptors

A clinical trial of Pain, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
2,007
Enrollment target
1
Study location

NCT00223366 is a study of Pain that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 2,007 participants, above the 299-participant average among 374 other Pain trials with a reported enrollment target (571% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00223366, a study of Pain, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
2,007 participants
Enrollment target
1
Study location

Study Summary

This protocol is for a number of in vitro studies using human surgical biopsies and evaluating the pharmacology and genetics of human nociceptors ("pain detecting") neurons

Conditions Studied

Study Locations (1)

Texas

  • The University of Texas Health Science Center at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 2,007 participants
Start Date 2001-10
Est. Completion 2019-05-19

What the Registry Record Tells You About NCT00223366

The ClinicalTrials.gov registry entry for NCT00223366 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,007 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 299-participant average among 374 other Pain trials with a reported enrollment target (571% higher). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 0 interventions.

NCT00223366 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00223366 about?

NCT00223366 is a clinical study titled "In Vitro Studies on Pharmacological Regulation and Genetic Risk Factors of Peripheral Human Nociceptors". This protocol is for a number of in vitro studies using human surgical biopsies and evaluating the pharmacology and genetics of human nociceptors ("pain detecting") neurons

What is the current status of trial NCT00223366?

This trial is currently completed. The enrollment target is 2,007 participants. The study started on 2001-10. Estimated completion is 2019-05-19.

What conditions does trial NCT00223366 study?

This clinical trial studies the following conditions: Pain.

Who is sponsoring clinical trial NCT00223366?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00223366 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.